Mechanically Ventilated Patients Clinical Trial
Official title:
Opioid vs. Benzodiazepine-based Sedation for Mechanically Ventilated Patients in the Internal Medicine Ward
Opioid-based sedation as a first line in mechanically ventilated patients has been considered the "gold standard" in intensive care unit patients around the world for several decades. Advantages of opiate-based sedation, compared to benzodiazepine-based sedation, which has been used in the past, include a reduction in delirium scores, better pain control, decreasing the time between cessation of sedation and patient awakening, and decreasing the time between cessation of sedation and extubation, with decreased ICU admission times. In most Western European countries, as well as in the United States, there are almost no mechanically ventilated patients hospitalized outside the intensive care unit. In a few countries, including Japan and Israel, mechanically ventilated patients are also hospitalized outside of intensive care units, as part of internal or surgical wards. Contrary to the vast knowledge accumulated regarding different sedation methods in ventilated patients in intensive care units, there are almost no studies that have evaluated different sedation methods in ventilated patients hospitalized in non-intensive care wards. Thus, while there is consensus on the benefits of opioid-based sedation in intensive care units, there is insufficient information to recommend the preferred sedation method in non-ICU wards. For various reasons, in a large number of the internal medicine wards of hospitals in Israel, the common sedation practice for ventilated patients is still benzodiazepine-based sedation. In the past year, a pilot program was initiated in Internal Medicine Department A at Meir Hospital in Kfar Saba, in which a new protocol for opioid-based sedation in ventilated patients was implemented. The protocol is based on the continuous intravenous infusion of fentanyl as the first line of treatment for sedation in ventilated patients only. If the sedation-agitation level (as measured by the RASS score) did not match the target RASS score set by the attending physician, a dose up to a maximum limit could be increased according to the protocol. Second-line sedation drugs were addition of continuous intravenous infusion of midazolam (in addition to fentanyl) in hemodynamically stable patients, or addition of continuous intravenous infusion of ketamine in unstable patients. In stable patients who did not reach the desired RASS level under continuous infusion of fentanyl and midazolam, ketamine could be added as a third line drug, in addition to fentanyl and midazolam.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06054503 -
Pilot Clinical Investigation to Evaluate a Prototype of Sensor Measuring Ventilator-derived Parameters
|
N/A | |
| Completed |
NCT01997931 -
The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients
|
N/A | |
| Completed |
NCT04134481 -
Effect Of Clustered Nursing Interventions On Physiological Response In Critically Ill Patients
|
||
| Completed |
NCT05588180 -
The Ratio Of Femoral Vein Diameter To Femoral Artery Diameter With Pulse Pressure Variation As A Diagnostic Tool
|
N/A | |
| Recruiting |
NCT06153498 -
PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
|
Phase 2 | |
| Recruiting |
NCT01256866 -
Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine
|
Phase 4 | |
| Completed |
NCT01237886 -
Weaning And Variability Evaluation
|
N/A | |
| Completed |
NCT00470821 -
Oral Melatonin in Critically Ill High-risk Patients
|
Phase 4 | |
| Completed |
NCT00322010 -
Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit
|
Phase 2 | |
| Completed |
NCT01090258 -
Pilot Evaluation of Closed Loop Ventilation and Oxygen Controller
|
N/A | |
| Completed |
NCT00199641 -
Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients
|
N/A | |
| Not yet recruiting |
NCT06182553 -
Effect of ERCC and/or PEEP-ZEEP Maneuver on Oxygenation, Ventilation, and Airway Secretions Removal in MV Patients
|
N/A | |
| Completed |
NCT03524937 -
Prevention of Delirium in Intensive Care by Melatonin
|
Phase 2/Phase 3 | |
| Completed |
NCT03333395 -
Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD
|
Phase 4 | |
| Completed |
NCT05387720 -
Concurrent Trigger Sensitivity Adjustment And Diaphragmatic Facilitation On Weaning From Mechanical Ventilation
|
N/A | |
| Recruiting |
NCT03800849 -
Mechanical Ventilation Practices in Uganda's Intensive Care Units
|
||
| Not yet recruiting |
NCT05480371 -
Cough Assist Device in Mechanically Ventilated Patients
|
N/A | |
| Completed |
NCT06124404 -
Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients
|
Phase 2 | |
| Completed |
NCT00935896 -
High Tidal Volume Induces Inflammation In Normal Lungs
|
N/A |